Correlation Between Eupraxia Pharmaceuticals and Acurx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Acurx Pharmaceuticals.
Diversification Opportunities for Eupraxia Pharmaceuticals and Acurx Pharmaceuticals
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eupraxia and Acurx is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Acurx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Acurx Pharmaceuticals
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to under-perform the Acurx Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals is 1.14 times less risky than Acurx Pharmaceuticals. The pink sheet trades about -0.14 of its potential returns per unit of risk. The Acurx Pharmaceuticals LLC is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 287.00 in Acurx Pharmaceuticals LLC on November 5, 2024 and sell it today you would lose (214.00) from holding Acurx Pharmaceuticals LLC or give up 74.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 32.93% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Acurx Pharmaceuticals LLC
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Acurx Pharmaceuticals LLC |
Eupraxia Pharmaceuticals and Acurx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Acurx Pharmaceuticals
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Inhibrx |
| Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |